Study hints at tools to prevent diabetes caused by psychiatr

New research points to a potential approach to reducing the risk of diabetes associated with widely prescribed antipsychotic medications. The study presents early evidence in support of co-administering antipsychotic medications that block dopamine receptors in the brain alongside drugs that stop antipsychotics from blocking those same receptors in the pancreas. This approach could limit metabolic side effects, including impaired control over blood sugar, or dysglycemia.

Related Keywords

Oregon , United States , Toronto , Ontario , Canada , Despoina Aslanoglou , Sandra Pereira , Barbara Slusher , Margaret Hahn , Aaron Janowsky , Zachary Farino , Alessandro Bonifazi , Amy Eshleman , Amy Hauck Newman , Gary Schwartz , Michael Ellenberger , Zachary Freyberg , University Of Toronto , Albert Einstein College Of Medicine , Pitt School Of Medicine , National Institutes Of Health , Johns Hopkins University , Oregon Health Science University , National Institutes , National Institute , Drug Abuse , Comfort Boateng , Rana Rais , Oregon Health , Science University , Albert Einstein College ,